Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Significant Decline in Short Interest

Retrieved on: 2022-06-12 14:49:27

Tags for this article:

Click the tags to see associated articles and topics

Calliditas Therapeutics AB (publ) (NASDAQ:CALT) Sees Significant Decline in Short Interest. View article details on hiswai:

Excerpt

Renaissance Technologies LLC purchased a new stake in Calliditas Therapeutics AB (publ) in the 3rd quarter worth approximately $294,000.

Article found on: www.etfdailynews.com